In clinical trials, high levels of SOX4 protein were positively correlated with status of differentiated degree, clinical stage, T classification, N classification, M classification in NSCLC, and the higher level of SOX4 expression was markedly correlated with poor overall survival in NSCLC patients (Wang et al., 2015). Here, SOX4 is linked to non-small cell lung carcinoma.